Source: Virtual Congress 2021 – Clinical year in review



Rating:

Share or cite this content

Citations should be made in the following way:
L. Richeldi (Roma, Italy). Interstitial lung disease: improving classification and prognosis. Virtual Congress 2021 – Clinical year in review

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary hypertension in interstitial lung disease: Non-invasive assessment for detection and prognosis Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Clinical characteristics of patients with unclassifiable interstitial lung disease Source: International Congress 2015 – New insights into IIPs Year: 2015 Interstitial lung disease; where do we stand without histopathology? Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013 A multicentre evaluation of inter-multidisciplinary team agreement for predicted disease behaviour and management strategy in diffuse lung disease Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases Year: 2016 Prevalence and prognosis of unclassifiable interstitial lung disease Source: Eur Respir J 2014; 43: 1529-1530 Year: 2014 Prevalence and prognosis of unclassifiable interstitial lung disease Source: Eur Respir J 2013; 42: 750-757 Year: 2013 The analysis of prognostic factors in patients with interstitial lung diseases Source: International Congress 2015 – New insights into IIPs Year: 2015 Different definitions of pulmonary hypertension in interstitial lung disease: a prognostic evaluation. Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020 Relevance of the expert ILD clinical-radiological evaluation of referred cases to the MDT Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Predictors of mortality and risk prediction among patients with scleroderma related interstitial lung disease Source: International Congress 2015 – IPF: clinical aspects II Year: 2015 Interstitial lung diseases: a clinical update Source: Eur Respir J 2001; 18: 1S Year: 2001 Chronic hypersensitivity pneumonitis: Is the interstitial pneumonias disease behavior classification suitable for outcome stratification? Source: International Congress 2015 – Interstitial lung diseases II Year: 2015 A multicentre evaluation of inter-multidisciplinary team agreement for diagnosis in diffuse lung disease Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases Year: 2016 Chronic obstructive pulmonary disease and interstitial lung disease could predict poor long-term survivals after pulmonary resection for lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 38s Year: 2002 Symptoms and quality of life in relation to lung function and comorbidities in patients with idiopathic pulmonary fibrosis: INSIGHTS-IPF registry Source: International Congress 2016 – IPF clinical Year: 2016 Multidisciplinary board for interstitial lung disease: Relevance for real life? Source: International Congress 2015 – New insights into IIPs Year: 2015 Radiologic pattern as a survival predictor in the rheumatoid artritis intersticial lung disease Source: International Congress 2015 – Connective tissue disorders Year: 2015 Safety and advantages of VATS biopsy in diagnosis of interstitial lung disease Source: International Congress 2015 – Challenges in surgery for non-malignant disorders: pleural mediastinal and tracheal problems, congenital disorders Year: 2015 Variation in mortality from interstitial lung disease by diagnosis Source: International Congress 2015 – IIPs: orphan Year: 2015 Factors predicting resolution in nitrofurantoin-induced lung disease Source: International Congress 2016 – Orphan diseases II Year: 2016